key: cord-0941618-j30mta2t authors: Zhang, Zili; Wang, Tao; Liu, Fei; Zhu, Airu; Gu, Guoping; Luo, Jieping; Xu, Jingyi; Zhao, Jincun; Li, Yiming; Li, Yuanyuan; Liu, Xiaoqing; Zhong, Nanshan; Lu, Wenju title: The proteomic characteristics of airway mucus from critical ill COVID-19 patients date: 2021-01-14 journal: Life Sci DOI: 10.1016/j.lfs.2021.119046 sha: 1ebd5a64441314d87636a87e799c86305866c8b5 doc_id: 941618 cord_uid: j30mta2t BACKGROUND: The pandemic of the coronavirus disease 2019 (COVID-19) has brought a global public health crisis. However, the pathogenesis underlying COVID-19 are barely understood. METHODS: In this study, we performed proteomic analyses of airway mucus obtained by bronchoscopy from severe COVID-19 patients. In total, 2351 and 2073 proteins were identified and quantified in COVID-19 patients and healthy controls, respectively. RESULTS: Among them, 92 differentiated expressed proteins (DEPs) (46 up-regulated and 46 down-regulated) were found with a fold change >1.5 or <0.67 and a p-value <0.05, and 375 proteins were uniquely present in airway mucus from COVID-19 patients. Pathway and network enrichment analyses revealed that the 92 DEPs were mostly associated with metabolic, complement and coagulation cascades, lysosome, and cholesterol metabolism pathways, and the 375 COVID-19 only proteins were mainly enriched in amino acid degradation (Valine, Leucine and Isoleucine degradation), amino acid metabolism (beta-Alanine, Tryptophan, Cysteine and Methionine metabolism), oxidative phosphorylation, phagosome, and cholesterol metabolism pathways. CONCLUSIONS: This study aims to provide fundamental data for elucidating proteomic changes of COVID-19, which may implicate further investigation of molecular targets directing at specific therapy. Coronavirus disease 2019 (COVID- 19) is an unprecedented global threat caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, it is rapidly spreading around the world. As of December 30, 2020, there are over 82,051,958 confirmed COVID-19 cases and about 1,792,251 deaths worldwide according to the situation report by WHO. Based on a recent study of 44,672 confirmed COVID-19 cases up to February 11 by the Chinese Center for Disease Control and Prevention, over 19% of COVID-19 patients developed severe or critical conditions [1] . Moreover, the mortality rate of COVID-19 in critically ill cases can be over 60%, posing a great pressure on treatment [2] . However, the biochemical and molecular changes associated with the severe form of COVID-19 are barely understood. In our clinic, we found it is common that the small airway and alveolar wall of critical ill COVID-19 patients were blocked with thick and sticky mucus, which contributes to the causes of difficult breathing [3] . In this study, we speculated that these mucus are a mixture of secretion by airway and alveolar epithelial cells in response to virus and inflammatory mediators, and the molecular changes may indicate the pathological changes of COVID-19. Proteomics is the huge fields that are equipped with sufficient technologies to face this challenge. Therefore, proteomics analysis was performed with the aim to provide fundamental information for understanding the pathogenesis of COVID-19, and for future development of therapeutic approaches. Inhibitor Cocktail). The remaining debris was removed by centrifugation at 12,000g at 4°C for 10min. Finally, the supernatant was collected and the protein concentration was determined with BCA kit according to the manufacturer's instructions. For digestion, the protein solution was reduced with 5mM dithiothreitol for 30min at 56°C and alkylated with 11mM iodoacetamide for 15min at room temperature in darkness. The protein sample was then diluted by adding 100mM TEAB to urea concentration less than 2M. Finally, trypsin was added at 1:50 trypsin-to-protein mass ratio for the first digestion overnight and 1:100 trypsin-to-protein mass ratio for a second 4h-digestion. For label-free quantification, protein expression levels were estimated using the iBAQ (Intensity Based Absolute Quantification) algorithm embedded in MaxQuant [5] . Briefly, normalization and the intensity-based absolute quantification (iBAQ) in MaxQuant was performed on the identified peptides to quantify protein abundance. In particular, shared peptides, which matched different protein groups, were excluded from quantification. Only proteins with a fold change > 1.5 or < 0.67 and a p-value < 0.05 in at least two biological replicates were considered to exhibit a significant difference in protein abundance between the two groups. The peptides were subjected to NSI source followed by tandem mass spectrometry (MS/MS) in Q ExactiveTM Plus (Thermo) coupled online to the UPLC. Peptides were then selected for MS/MS using NCE setting as 28 and the fragments were detected in the Orbitrap at a resolution of 17,500. Principal database (http://www.ebi.ac.uk/GOA/). Proteins were classified by GO annotation into three categories: biological process, cellular compartment, and molecular function. For each category, a two-tailed Fisher's exact test was employed to test the enrichment of the differentially expressed protein (DEPs) against all identified proteins. The GO with a corrected p-value of < 0.05 was considered significant. Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used to identify enriched pathways. In this context, we used the two-tailed Fisher's exact test to examine the enrichment of the DEPs against all identified proteins. The pathway with a corrected p-value of < 0.05 was considered significant. All DEPs database accession or sequence were searched against the STRING database version 10.1 for protein-protein interactions (PPI). Meanwhile, STRING defines a metric called "confidence score" to define interaction confidence; we fetched all interactions that had a confidence score of ≥ 0.7 (high confidence). Interaction network form STRING was visualized in R package "networkD3". For further hierarchical clustering based on DEPs functional classification. Cluster membership were visualized by a heat map using the "heatmap.2" function from the "gplots" R-package. Continuous variables were presented as median (IQR). Categorical variables were presented as n (%). All analyses were done with GraphPad Prism 5 software, using two-sided p values. Statistical significance was set at p < 0.05. The clinical characteristics of COVID-19 patients and healthy controls are shown in Table 1 . There were no significant differences regarding baseline characteristics between both groups as regards to age, gender, and smoking status. Table S1 . In the quality control analysis, PCA, the median Relative SD (RSD) of all internal standards in each sample, protein mass and coverage distribution, and protein sequence distribution were calculated ( Figure S1 ). Our data were acquired with a high degree of consistency and reproducibility. factors were associated with the outcomes of COVID-19 and were consistent with studies published [18] [19] [20] [21] [22] [23] [24] . Our study has some limitations. First, for all patients, airway mucus obtained by bronchoscopy, which might be a mixture of secretion by airway and alveolar epithelial cells in response to virus and inflammatory mediators. But for healthy controls, it was not ethical to obtain airway mucus via bronchoscopy, therefore induced sputum was used instead, and the content and counts of sputum cell may be different. Second, because this study is retrospective, not all laboratory tests were done in all participants such as IL-6, D-dimer and lactate dehydrogenase. Therefore, their influences on outcomes might be underestimated. Third, with the limited number of participants, it is difficult to assess host risk factors for disease severity with multivariable adjusted methods. Collection of standardized data from a larger cohort with a full picture of the spectrum of clinical severity combined with proteomic data would help to better understand the pathogenesis of this disease. The proteomic datasets of COVID-19 patients' airway mucus are highly valuable resources for better understanding of the host proteomic changes associated with COVID-19. This will further expand our knowledge about the pathological changes of COVID-19, and provide hints of potential therapeutic strategies. Epidemiology Working Group for Ncip Epidemic Response CCfDC and Prevention Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients Reproducibility of fluid-phase measurements in PBS-treated sputum supernatant of healthy and stable COPD subjects Global quantification of mammalian gene expression control Viral hijacking of cellular metabolism Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways Far upstream element binding protein 1: a commander of transcription, translation and beyond Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase Roles of Aldolase Family Genes in Human Cancers and Diseases Structural insight into proteolytic activation and regulation of the complement system Complement system in lung disease Complement in lung disease Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio FGB and FGG derived from plasma exosomes as potential biomarkers to distinguish benign from malignant pulmonary nodules Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation Immune Response and COVID-19: A mirror image of Sepsis Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation We sincerely thank all the healthcare providers fighting against this public crisis and all the patients involved in the study. We express sincere sympathies and deep condolences to the victims and bereaved families.